What one share of Elite Pharmaceuticals holds
Elite Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.12 |
|---|---|
| Profit | $0.04 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | $0.02 |
| Cash and investments | $0.04 |
| Book value | $0.10 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $0.04 | −$0.14 | $0.00 | $0.01 | — | −$0.10 |
| 2012 | $0.01 | −$0.06 | $0.00 | −$0.00 | — | −$0.05 |
| 2013 | $0.01 | −$0.00 | $0.00 | −$0.00 | — | −$0.02 |
| 2014 | $0.01 | −$0.21 | $0.00 | −$0.01 | — | −$0.14 |
| 2015 | $0.01 | −$0.02 | $0.00 | −$0.02 | — | −$0.06 |
| 2016 | $0.02 | −$0.01 | $0.00 | −$0.01 | — | −$0.05 |
| 2017 | $0.01 | −$0.01 | $0.00 | −$0.01 | — | $0.03 |
| 2018 | $0.01 | −$0.01 | $0.00 | −$0.01 | — | $0.01 |
| 2019 | $0.01 | −$0.01 | $0.00 | −$0.01 | — | −$0.00 |
| 2020 | $0.02 | −$0.00 | $0.00 | −$0.00 | — | $0.01 |
| 2021 | $0.03 | $0.00 | $0.00 | $0.00 | — | $0.00 |
| 2022 | $0.03 | $0.01 | $0.00 | $0.01 | — | $0.01 |
| 2023 | $0.03 | $0.00 | $0.01 | −$0.00 | — | $0.01 |
| 2024 | $0.06 | $0.02 | $0.00 | −$0.00 | — | $0.05 |
| 2025 | $0.08 | −$0.00 | $0.00 | $0.01 | — | $0.05 |
| 2026 | $0.13 | $0.03 | $0.00 | $0.02 | — | $0.09 |
Common questions about Elite Pharmaceuticals
How much does one share of Elite Pharmaceuticals earn?
Over the last 12 months, each share of Elite Pharmaceuticals earned $0.04 of profit on $0.12 of sales, keeping about 35¢ of every $1 (profit margin).
Does Elite Pharmaceuticals pay a dividend?
Elite Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Elite Pharmaceuticals’s book value per share?
Elite Pharmaceuticals’s book value is $0.10 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Elite Pharmaceuticals have?
Each share of Elite Pharmaceuticals has $0.04 of cash and investments, as of June 30, 2026.
What is Elite Pharmaceuticals’s free cash flow per share?
$0.02 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Elite Pharmaceuticals bought back shares?
Elite Pharmaceuticals’s share count rose about 1073% from 2011 to 2026. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.